P246: Persistent burden of disease in patients with Crohn’s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)ECCO'22Year: 2022
Authors: Sikirica, M.(1);Lynch, J.(2);Kershaw, J.(3);Lukanova, R.(3);Baker, S.(3);Milligan, G.(3);
(1)Janssen, Market Access, Horsham, United States;(2)Janssen Research & Development- LLC, Immunology, Horsham, United States;(3)Adelphi Real World, Autoimmune, Bollington, United Kingdom;
P247: Comparison of discontinuation/switching between infliximab biosimilar and originator among Inflammatory Bowel Disease patients: a real-world analysis of two Canadian cohortsECCO'22Year: 2022
Authors: Moura, C.S.(1);Lukusa, L.(1);Wong, E.C.(2);Lakatos, P.L.(3);Afif, W.(3);Narula, N.(2);Bernatsky, S.(3);
(1)McGill University Health Centre, Centre for Outcomes Research and Evaluation, Montreal, Canada;(2)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(3)McGill University, Department of Medicine, Montreal, Canada;
P248: Lifestyle changes after Inflamatory Bowel Disease diagnosis.ECCO'22Year: 2022
Authors: Belén Galipienso, O.(1);Cameo, J.(1);Bernabeu, P.(2);Mira, C.(1);García, M.D.M.(3);Pomares, C.(4);Muñoz, D.(5);Canales, N.(2);Gutierrez, A.(1);Zapater, P.(6);van-der Hofstadt, C.(2);Jover, R.(1);Ruiz, M.T.(7);Sempere, L.(1);
(1)General University Hospital-Alicante. ISABIAL., Gastroenterology Department, Alicante, Spain;(2)General University Hospital-Alicante. ISABIAL., Health Psychology Department, Alicante, Spain;(3)University Hospital-San Juan, Gastroenterology Department, Alicante, Spain;(4)General University Hospital-Elche, Gastroenterology Department, Elche, Spain;(5)University and Polytechnic La Fe Hospital, Gastroenterology Department, Valencia, Spain;(6)General University Hospital-Alicante. ISABIAL. CIBEREHD, Pharmacology Department, Alicante, Spain;(7)University of Alicante. CIBERESP., Public Health Department, Alicante, Spain;
P249: Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse.ECCO'22Year: 2022
Authors: Veyrard, P.(1);Roblin, X.(2);Mao, R.(3);Nancey, S.(4);waeckel, L.(5);Berger, A.E.(6);Williet, N.(7);Bastide, L.(7);Barrau, M.(7);tournier, Q.(7);Paul, S.(6);
(1)CHU SAINT-ETIENNE, gastro enterology, Saint-Priest-en-Jarez, France;(2)chu saint etienne, gastro enterology, Saint-Priest-en-Jarez, France;(3)Hospital of Sun Yat-sen University, Inflammation and immunity, guangzhou, China;(4)chu Lyon sud, Gastroenterology, Lyon, France;(5)chu st etienne, immunology, Saint etienne, France;(6)CHU Saint etienne, Immunology, Saint Etienne, France;(7)CHU saint etienne, Gastroenterology, Saint etienne, France;
P250: Clinical validation of a point of care test for fecal calprotectin in distinguishing irritable bowel syndrome from Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Bray, K.(1);Bahur, B.(2);Yadav, M.(3);Skinner, M.(3);Wong, M.(3);Chon, K.(3);Huang, R.(3);Day, V.(3);Mimms, L.(3);Hale, M.(3);
(1)ProciseDx Inc., Clinical Development and Medical Affairs, San Diego, United States;(2)ProciseDx Inc., Clinical Operations, San Diego, United States;(3)ProciseDx Inc., Research and Development, San Diego, United States;
P251: Endoscopic and pathologic findings of the esophago-gastroduodenal involvement of Crohn’s disease in Korea: a prospective cohort studyECCO'22Year: 2022
Authors: Kim, G.H.(1);Kim, J.(2);Park, S.H.(1);Ahn, J.Y.(1);Ye, B.D.(1);Jung, H.Y.(1);Yang, S.K.(1);
(1)Asan Medical Center University of Ulsan College of Medicine, Gastroenterology, Seoul, Korea- Republic Of;(2)Asan Medical Center University of Ulsan College of Medicine, Pathology, Seoul, Korea- Republic Of;
P252: Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center.ECCO'22Year: 2022
Authors: Viola, A.(1);Demarzo, M.G.(2);Abbruzzese, A.(1);Chiappetta, M.F.(1);Costantino, G.(1);Alibrandi, A.(3);Fries, W.(1);
(1)University of Messina., IBD-unit- Dept. of Clinical and Experimental Medicine., Messina, Italy;(2)University of Genoa- Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Gastroenterology Unit- Department of Internal Medicine., Messina, Italy;(3)University of Messina., Department of Economics- Unit of Statistical and Mathematical Sciences, Messina, Italy;
